4 Healthcare Stock Stories Buzzing Away on Wednesday
Vivus Inc. (NASDAQ:VVUS): Closing price $10.16
BofA/Merrill Lynch on Wednesday maintained its Buy on Vivus, along with a price target at $17. The firm’s new Chief Executive Seth Fischer, commenting upon a potential partnership deal for Qsymia, said that discussions with potential partners are going well, adding that talks had not stalled because of management changes and that potential partners are not worried about Qsymia IP problems. Fischer said that Vivus would expand its sales force if can not secure a partner.